跳至主要内容
临床试验/NCT01008605
NCT01008605已完成3 期

Representative Users Study Of Operating Characteristics Of The Caverject Delivery System.

Pfizer3 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2011年2月最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
Pfizer
入组人数
48
试验地点
3
主要终点
Percentage of Participants Who Successfully Operated the Caverject Impulse Delivery System

研究概览

简要总结

The purpose of this study is to demonstrate the usability of the system.

详细描述

demonstrate usability

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
盲法
None

入排标准

年龄范围
40 Years 至 70 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Age 40 to 70

排除标准

  • Prior syringe skills

结局指标

主要结局

Percentage of Participants Who Successfully Operated the Caverject Impulse Delivery System

时间窗: Day 1

Percentage of participants who were able to successfully expel the selected dose from the Caverject Impulse Delivery System when relying on the modified Instructions for Use. The process was considered successful if the lower bound of the 95% confidence interval (CI) was more than (\>) 80% overall.

次要结局

  • Number of Participants With Categorical Responses to the Participant Assessment Tool: Question 3(Day 1)
  • Number of Participants With Categorical Responses to the Participant Assessment Tool: Question 2(Day 1)
  • Number of Participants Providing Comments to Any Question on the Participant Assessment Tool(Day 1)
  • Number of Participants With Categorical Responses to the Participant Assessment Tool: Question 1(Day 1)
  • Number of Participants With Categorical Responses to the Participant Assessment Tool: Question 4(Day 1)
  • Time Required to Perform Each Step While Using the Caverject Impulse Delivery System(Day 1)

研究者

发起方
Pfizer
申办方类型
Industry
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验